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Aim: This study examines the trends and outcomes of breast cancer patients who have undergone
surgical procedures at the Department of Surgical Sciences, University of Insubria, Varese, Italy. It also
identiﬁes the factors that contributed to the reduction of the breast tumor size over a 13-year period at
a tertiary referral center.
Methods: All breast cancer operations performed at the Department of Surgical Sciences, University of
Insubria, Varese, Italy, from January 1992 to June 2005 were examined and data from their surgical
pathology reports were also analyzed, using a prospective database. A longitudinal study was performed
to compare and analyze the pathological data during three consecutive time periods. The periods were
from 1992 to 1996, 1997 to 1999, and 2000 to 2005. Surgical and pathological outcomes included age of
the patient at the time of the diagnosis, partial breast resections, mastectomies, axillary lymphadenec-
tomies, tumor size, histological type and stage, and lymph node status.
Results: The study group was comprised of 3050 patients who underwent breast resection between 1992
and 2005. Quadrantectomy was the preferred surgical approach in 1759 patients (58%). Throughout the
longitudinal study, the tumors measuring less than 1 cm increased from 13.4% to 15.4%; the number of
tumors diagnosed at stage I increased from 44.1% to 56.8%; the most frequent histological type was
ductal carcinoma; the number of ductal carcinomas in situ (DCIS) increased from 4% to 6%; and the
incidence of lymphadenectomies decreased from 71.6% to 52.5%. Perioperative factors that correlated
with the decreased size of the tumor over time were: screening, improvement of diagnostic and ther-
apeutic techniques, and the increased operative use of sentinel lymph node biopsy (SLNB).
Conclusions: There has been an evolving reﬁnement in surgical technique and perioperative manage-
ment of breast cancer patients undergoing surgical resection at the Department of Surgical Sciences,
University of Insubria, Varese, Italy, during the past decades. The present longitudinal study on 3050
surgical breast cancer patients conﬁrmed the progressive reduction of tumor size at the time of the
diagnosis. Perioperative factors that correlated with the decreased tumor size over time were
mammography screening, improvement of diagnostic and therapeutic techniques, and the use of SLNB.
Furthermore, the study showed that the progressive reduced number of useless axillary lymphadenec-
tomies was mainly due to the increased intraoperative use of axillary SLNB.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Breast cancer is the third most frequent cancer in the world and
themost commonmalignancy inwomen. It is theﬁfth causeof death
from cancer overall (following lung, stomach, colorectal and liver
cancers) and is the leading cause of cancer mortality in women. ItRovera).
ciates Ltd. Published by Elsevier Ltrepresents about 14% of all cancer deaths among women, with the
overall incidence rate increasing by 0.5%.1 Approximately
1.35 millionnewcasesworldwideareestimated for theyear2010.2–4
In Italybreast cancer isalsothemost frequentmalignancyaffecting
the female population. It is estimated that about 35,000 new cases of
breast cancers are diagnosed every year constituting about 14% of
female cancers. These breast cancer diagnoses have a mortality rate
of 12,000 women a year.5–7 In the Province of Varese, about 700
women develop breast cancer each year,8 with the probability for
a woman to develop breast cancer being 1/10 (10%) in her life time.d. All rights reserved.
1992–1996 1997–1999 2000–2005
tage III 116 (14.5%) 118 (13.5%) 146 (10.7%)
tage II 334 (41.4%) 348 (40%) 446 (32.5%)
tage I 356 (44.1%) 407 (46.5%) 779 (56.8%)
1992–1996 1997–1999 2000–2005
>3 cm 184 (23%) 217 (24.8%) 209 (15.2%)
1–3 cm 514 (63.6%) 559 (64.2%) 951 (69.4%)
<1 cm 108 (13.4%) 97 (11%) 211 (15.4%)
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diagnosed when the disease was in an advanced stage and already
possessing symptoms and signs related to the tumor. Often these
patients had clinical evidence of systemic neoplastic disease with
poor prognosis.9–11 Analyzing different series of patients affected
by breast cancer reported in the literature12–14 it appears that in
recent years there has been a worldwide increase in the number of
patients with stage I disease, which suggests an increase in the
early detection of breast cancer cases. This is mainly due to the
improvement in the diagnostic techniques, mainly from breast
ultrasound and the development of new technologies for the
diagnosis of non -palpable breast lesions, such as the routine two-
view X-ray of each breast. Additionally, the extensive mammog-
raphy screening programs for breast cancer have improved the
diagnosis of the disease. Screenings are currently used to evaluate
asymptomatic, healthy women via a routine two-view X-ray of
each breast in the effort to detect unsuspected breast cancer. To
date, detection of asymptomatic tumors is the best way to reduce
mortality from breast cancer. Due to the screening programs, there
was a global mortality reduction of approximately 30– 40%.15,16 As
a consequence of early diagnosis, the 5-year disease-free survival
rate signiﬁcantly improved, reaching about 90% in those patients
with small tumors without lymph node involvement.17 The
increased detection of early breast lesions led as a consequence to
a signiﬁcant reduction of demolitive surgical procedures as well as
to a positive impact on the rate of complications and the quality of
life of the patient. As a result of the widespread use of breast
conserving surgery18,19 during the past few years, the trend
towards conservatism has increased and has quickly changed the
standard of surgical treatment.
In recent years, trained and experienced centers have reported
a signiﬁcant reduction of breast tumor size at the time of diag-
nosis.20 As largely shown, tumor size has a positive correlationwith
the odds of nodal involvement. Consequently a smaller sized tumor
at diagnosis correlates to a lower stage of breast disease.
The decrease in tumor size and the lower stage determination at
diagnosis have been mainly attributed to increased mammography
screening and to greater awareness of the disease as well as the
importance of breast examination. As previously shown by other
authors, the exact assessment of breast tumor size depends on
more than just the tumor size itself, but also on method and
histopathology.21 Authors agree that the only precise method to
evaluate the exact size of a tumor is by pathology assessment.
On the basis of these considerations a longitudinal study of 3050
patients who have undergone breast surgery for cancer between
1992 and 2005, at the Department of Surgical Sciences of the
University of Insubria, was carried out in order to verify and
quantify the reduction of tumor growth at diagnosis. This evalua-
tion showed an increasing trend towards conservative surgery for
breast cancer and evaluated the decreased percentage of unnec-
essary complete axillary lymphadenectomies secondary to the
introduction of intraoperative sentinel lymph node biopsy.
This study was conducted in cooperation with the Pathology
Department of the University, which provided the pathologic
characteristics of each breast cancer case.
2. Patients and methods
The medical records and the pathology reports of 3050
patients, who had undergone resection for breast cancer between
1992 and 2005, were accurately reviewed and the data registered
on a database. The review and registration process was carried
out by a group of physicians from the Department of Surgical
Sciences together with the Pathology Department of the same
University to ensure the validity and accuracy of the datacollection, and under the supervision of the principal
investigators.
Patients that did not receive surgical therapy for documented
metastatic disease and/or for prohibitive medical–surgical risks
were excluded.
For each patient enrolled in this observational study, the
following data were registered: gender, age at diagnosis, type of
surgical resection, sentinel lymph node biopsy (with the total
number of lymph nodes for each axillary level), histological type,
tumor size and pathological staging. These data were registered in
a computerized database which allowed the use of statistical
analysis, including Student’s t-test and chi-square test. Statistical
signiﬁcance was accepted when the p value was <0.05.
Patient outcome was analyzed over three consecutive time
periods: 1992– 1996, 1997– 1999, and 2000– 2005.
3. Results
Among the 3050 patients enrolled, 806 underwent surgical
procedures during the period of 1992–1996, 873 during the period
of 1997–1999 and 1371 during the period of 2000–2005.
The analysis of tumor size was performed on the pathology
specimen and this demonstrated a progressive decrease of the
tumor diameter from 1992 to 2005. Breast cancers greater than
3 cm during the time periods 1992– 1996, 1997– 1999, and 2000–
2005 were 23%, 24.8% and 15.2% respectively. The percentage
diameters of breast cancers lower than 1 cm were 13.4%, 11% and
15.4% respectively (p < 0.001).0
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The analysis of the age of the patients at diagnosis was per-
formed and this demonstrated that the mean agewas similar in the
three time periods: 59 years old during the period of 1992–1996,
61 years old during the period of 1997–1999 and 62 years old
during the 2000–2005 period.
The analysis of tumor stage at the time of the diagnosis
demonstrated a progressive decrease of tumor stage from III to I for
the period of 1992–2005. Breast cancers in stage III for the time
periods of 1992– 1996, 1997– 1999, and 2000– 2005 were 14.5%,
13.5% and 10.7% respectively. Breast cancers in stage I for the time
periods of 1992– 1996, 1997– 1999, and 2000– 2005 were 44.1%,
46.5% and 56.8% respectively (p < 0.001).S
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1992–1996 1997–1999 2000–2005
Lymphadenectomy 577 (71.6%) 640 (73.3%) 720 (52.5%)
Positive lymph node(s) 306 (53%) 297 (47%) 474 (46%)
Negative lymph node(s) 271 (47%) 343 (53%) 246 (34%)
F. Rovera et al. / International Journal of Surgery 6 (2008) S97–S100 S99The analysis of the type of surgical treatment performed on the
patients showed a progressive decrease of mastectomies during the
1992–2005 period. Mastectomies for the time periods 1992– 1996,
1997– 1999, and 2000– 2005 were 52.4%, 44.2% and 35% respec-
tively. Conservative surgery for the time periods 1992– 1996,1997–
1999, and 2000– 2005 were 47.6%, 55.8% and 65% respectively
(p < 0.001). These data conﬁrm the tendency towards conservative1992–1996 1997–1999 2000–2005
Mastectomy 423 (52.4%) 386 (44.2%) 482 (35%)
Conservative surgery 383 (47.6%) 487 (55.8%) 889 (65%)
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1997-1999surgery of breast cancer, since it has been demonstrated that breast
cancer is a systemic disease and it must also be treated with
radiotherapy and chemotherapy, when clinically appropriate.1992–1999 2000–2005
DCIS 39 (4%) 82 (6%)
Non-DCIS 1154 (96%) 1289 (94%)The present study conﬁrmed that the most frequent histological
typediagnosedwas invasiveductal carcinoma(IDC). From1992to2005
the numberof ductal carcinoma in situ (DCIS) increased from4%during
the 1992–1999period to 6% in the 2000–2005period. Inparticular, this
was due to the introduction of mammography screening that gave the
possibility to evaluate non palpable breast lesions, which presented by
imaging as microcalciﬁcations and/or parenchymal distortions.
The analysis of the type of the performed lymphadenectomies
demonstrated a progressive decrease of total axillary lymphadenec-
tomies from 1992 to 2005. Total axillary lymphadenectomies for the
time periods 1992– 1996, 1997– 1999, and 2000– 2005 were 71.6%,
73.3% and 52.5% respectively. This was due to the introduction of the
axillary sentinel lymph node biopsy technique.0
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Negative LN4. Conclusions
This longitudinal study on 3050 surgical breast cancer cases
conﬁrmed the progressive reduction of tumor size at the time of the
diagnosis during the last decades. Perioperative factors that
correlated with the decreased tumor size over time were
mammography screening and the improvement of diagnostic and
therapeutic techniques. In addition, the study showed that the
progressive reduced number of useless axillary lymphadenec-
tomies was mainly due to the increased intraoperative use of
axillary sentinel lymph node biopsies.
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